1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice
pharmalaw
Last Activity:
Oct 8, 2019 at 10:44 AM
Joined:
Oct 8, 2019
Messages:
3
Likes Received:
0
Trophy Points:
1
Gender:
Male

Share This Page

pharmalaw

new user, Male

pharmalaw was last seen:
Oct 8, 2019 at 10:44 AM